MIRALEK is a growing group of companies with several divisions in its structure. We focus on providing various veterinary industries with high quality products! Our products improve the economic performance of organizations working with farm animals and pets.
Products under our brand include a wide range of veterinary drugsproduced on our own production lines (antibacterial, antimastitic, and antiparasitic drugs, etc.). MIRALEK´s product lines include not only its own products, but also a full range of veterinary and sanitary drugs and equipment for farming and veterinary medicine.Read more
THE MIRALEK GROUP HAS WORKED IN RUSSIA FOR MORE THAN 8 YEARS
Miralek Group is one of the leading pharmaceutical companies in Russia with its branches in Novosibirsk, Voronezh, Krasnodar, and Moscow.
In 2022, the company celebrated 8 years of operations in Russia.
The company's medicines are included in current recommendations and standards of treatment for pets and farm animals.
The company employs more than 70 people.
Miralek´s daily activities are based on the principles of responsible and ethical approach to business, based on openness, transparency, and compliance with all laws and regulations. The company builds its relationships with the veterinary community and partners based on the principles of mutual respect, trust, open and equal terms of cooperation.×
To date, more than 90% of Miralek's portfolio of drugs is produced on a full cycle basis at pharmaceutical plants in Russia. The main part of our products are therapies for skin diseases, anesthetics, and pain relief agents, the need for which is constantly growing in Russia. More than 800 million packs have been produced since the company was founded.
Miralek Group has become one of Russia's first pharmaceutical companies to transfer modern drug manufacturing technologies to Russia, producing veterinary drugs at high-tech facilities of full cycle, operating in full compliance with the international Good Manufacturing Practice (GMP) standard.×
Miralek has been successfully cooperating in preclinical and clinical development of new drugs with leading research institutes, educational and veterinary institutions for over 8 years. Over these years, more than 30 clinical trials have been conducted in 15 Russian cities, with the participation of more than 20 patients.
The Miralek Group also includes units for quality control, pharmacovigilance and veterinary information analysis, logistics, and staff development.
Such structure makes it possible to organize and conduct clinical trials as quickly and efficiently as possible, ensuring patient safety and reliability of the resulting data, which is the company´s absolute priority×
For Miralek Group, it is an integral part of the company's development strategy. The company applies social responsibility principles to its relationship with the world around it.×
R&D Research and DevelopmentAt the moment we are developing more than 20 generics and original drugs that are not produced in the Russian Federation. The company is developing processes to produce substances and auxiliary components for the pharmaceutical and microbiological industry that are not currently manufactured in Russia. We believe in evidence-based veterinary medicine and adhere to international pharmacopoeia rules.
ProductionWe monitor quality at every stage of production, carefully select suppliers of raw materials and components, conduct regular audits of their production facilities. We have to purchase many materials abroad, which affects the price, but this is the only way to guarantee quality. Each batch of components undergoes incoming inspection for compliance with the regulatory documents, and they can be used in production only after a positive opinion of the quality service.
State-of-the-art laboratoryWe employ chemists and technologists of the highest level, develop technological processes for the production of veterinary drugs and animal hygiene products, organize preclinical and clinical trials, we validate analysis methods, study the stability of samples of substances and drugs, prepare documentation for state registration.
Functional Treat Milojik Uro D-Mannose+Cranberry for big pets
Helps normalize metabolism.
It improves coat condition in dogs and cats.
High bioavailability of the components.
Ingredients: Functional treat Milogic Skin Omega 3+6 contains sunflower oil, fish oil, evening primrose oil, vitamin e, and ionol. 100 grams of product contains 0 g carbohydrates, 0 g proteins, and 0 g fat. Energy value per 100 g: 890 kcal.
The functional treat contains at least 40% linoleic acid, at least 0.7% of γ-linolenic acid, at least 4.0% eicosapentaenoic acid, at least 2.8% docosahexaenoic acid and at least 4 IU/ml of vitamin E.
Description: Oil solution.
Use: Functional treat Milogic Skin Omega 3+6 is used to normalize metabolism in cats and dogs, and to improve the condition of their coat. Linoleic acid helps to restore cell membranes and enhance barrier functions of the skin. Eicosapentaenoic and docosahexaenoic acids reinforce cell membranes and increase the integrity of the animal's skin. γ-linolenic acid is metabolized in animals to thromboxanes and prostanoids, which have anti-inflammatory effects. Fat-soluble vitamin E acts as a universal anti-oxidation protector of polyunsaturated fatty acids in the cell wall.
Dosage and how to use: Functional treat Milogic Skin OMEGA 3+6 is recommended for dogs and cats once a day with a dosage of 5 ml per every 10 kg of animal weight. It can be added to feed or be used separately.
Storage life of Functional treat Milogic Skin Omega 3+6, in the appropriate storage conditions in the closed original package: 2 years from the date of manufacture.
the company's turnover>15% of turnover is invested
>20 candidate drugs in clinical developmentOver 8 years of successful cooperation in preclinical and clinical development of new drugs with leading research institutes, educational and veterinary institutions.
7 agreements for clinical trialsThe structure of the company makes it possible to organize and conduct clinical trials as quickly and efficiently as possible, ensuring patient safety and reliability of the resulting data, which is the company´s absolute priority
Miralek employs more than 70 people all over the country.The Group's employees regularly improve their skills and undergo additional training
2 production sitesProduced at certified sites of the Russian Federation and Belarus
Central office in Moscow
Phone: +7 (499) 110-14-35
Address: Moscow, Dmitrovskoe highway 9a,str 5Address: Moscow, Dmitrovskoe highway 9a,str 5 Opening hours Mon-Thu 9-18, Fri 9 - 17
Phone: +7 (861) 205-02-31
Address: ul. Imeni Sorokaletiia Pobedy, 33/7Address: ul. Imeni Sorokaletiia Pobedy, 33/7